Choana of a desert tortoise, Gopherus agassizii, with upper respiratory tract disease, 1991
Biosafety Level
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
freeze-dried
Preceptrol®
no
Type Strain
yes
(type strain)
Comments
Causes upper respiratory disease in the Desert Tortoise, Gopherus agassizii
Referred to as the type strain
Medium
ATCC® Medium 2611: Spiroplasma medium
Growth Conditions
Temperature: 30.0°C
Atmosphere: broth: aerobic; agar: 5% CO2 (candle jar)
Name of Depositor
MB Brown
Year of Origin
1991
References
Brown MB, et al. Mycoplasma agassizii causes upper respiratory tract disease in the desert tortoise. Infect. Immun. 62: 4580-4586, 1994. PubMed: 7927724
Brown DR, et al. Taxonomic analysis of the tortoise mycoplasmas Mycoplasma agassizii and Mycoplasma testudinis by 16S rRNA gene sequence comparison. Int. J. Syst. Bacteriol. 45: 348-350, 1995.
Brown MB, et al. Mycoplasma agassizii sp. nov., isolated from the upper respiratory tract of the desert tortoise (Gopherus agassizii) and the gopher tortoise (Gopherus polyphemus). Int. J. Syst. Evol. Microbiol. 51: 413-418, 2001. PubMed: 11321087
